This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cushman, J.
Right arrow Articles by Petitto, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cushman, J.
Right arrow Articles by Petitto, J. M.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, January 2003, p. 13-18, Vol. 10, No. 1
1071-412X/03/$08.00+0     DOI: 10.1128/CDLI.10.1.13-18.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Neurobehavioral Changes Resulting from Recombinase Activation Gene 1 Deletion

Jesse Cushman,1 Jeannette Lo,1 Zhi Huang,1 Clive Wasserfall,2 and John M. Petitto1,3,4*

Departments of Psychiatry,1 Neuroscience,3 Pharmacology, McKnight Brain Institute,4 Department of Pathology and the Center for Immunology and Transplantation, University of Florida College of Medicine, Gainesville, Florida2

Received 8 July 2002/ Returned for modification 6 September 2002/ Accepted 17 September 2002

Recombinase activation gene 1 (RAG-1) function is essential for V(D)J recombination in T-cell-receptor and immunoglobulin rearrangements whereby the immune system may encode memories of a vast array of antigens. The RAG-1 gene is also localized to neurons in the hippocampal formation and related limbic regions that are involved in spatial learning and memory as well as other parameters of neurobehavioral performance. Since the unique ability to encode memory is shared by the immune system and the brain, we tested the hypothesis that loss of the RAG-1 gene in the brain would influence learning and memory performance and examined several different domains of behavior in RAG-1-knockout and control mice. Compared to control mice, RAG-1-knockout mice exhibited increased locomotor activity in an open field under both dim and bright lighting conditions and decreased habituation (reduction in the expected decline in locomotor activity with increasing familiarity with the novel environment in a 1-h test session) in bright lighting. RAG-1-knockout mice also showed reduced levels of fearfulness for some measures of fear-motivated behavior in both the open-field behavior test and elevated-plus maze test. Contrary to our hypothesis, no differences in spatial learning and memory were found between the groups, although modest differences were observed visible-platform testing in the Morris water maze. Neither prepulse inhibition, a measure of sensorimotor gating, nor reflexive acoustic startle responses differed between the RAG-1-knockout and control mice. It remains to be determined if these changes are due to the loss of RAG-1 gene expression in the brain, are due to the absence of the gene in the immune system (e.g., the loss of cytokines with neuromodulatory activities), or are due to some combination of both effects. Study of the neurobiological actions of RAG-1 in the brain may provide new insights into important processes involved in normal brain function and disease.


* Corresponding author. Mailing address: McKnight Brain Institute, Box 100256, University of Florida College of Medicine, Gainesville, FL 32610-0256. Phone: (352) 294-0416. Fax: (352) 392-2579. E-mail: jpetitto{at}psych.med.ufl.edu.


Clinical and Diagnostic Laboratory Immunology, January 2003, p. 13-18, Vol. 10, No. 1
1071-412X/03/$08.00+0     DOI: 10.1128/CDLI.10.1.13-18.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.